New Delhi, April 26 -- In the wake of India's suspension of the Indus Water Treaty following the Pahalgam terror attack, Pakistan has retaliated by halting all trade with New Delhi. This abrupt cessation has prompted Pakistani health authorities to initiate "emergency preparedness" measures to safeguard pharmaceutical supplies, as the country relies on India for 30-40% of its pharmaceutical raw materials, including Active Pharmaceutical Ingredients (APIs) and advanced therapeutic products.

The Drug Regulatory Authority of Pakistan (DRAP) has confirmed that contingency plans are in place, though no formal notification has yet been issued regarding the ban's impact on the pharmaceutical sector. DRAP officials stated that preparations for s...